Fortinet Gains From SASE & SecOps Momentum: More Upside Ahead?

Fortinet (FTNT) reported strong Q2 2025 performance, with Unified SASE billings up 21% and SecOps billings jumping 31%, contributing to a more than 50% increase in deals over $1 million. This robust enterprise demand prompted management to raise its full-year billings outlook midpoint by $100 million, projecting 2025 revenue growth of 12.8% to $6.72 billion and total billings growth of 13.9% to $7.44 billion. Despite this operational momentum, FTNT shares have declined 19% year-to-date, underperforming the industry, and the stock appears overvalued with a Price/Book ratio of 28.45X compared to the industry's 20.4X.

Analysis

Fortinet is demonstrating significant operational momentum, driven by the rapid adoption of its Unified SASE and SecOps solutions, which saw billings grow 21% and 31% year-over-year, respectively, in Q2 2025. This growth in strategic, recurring revenue streams now accounts for approximately 35% of total billings and is fueling success in the enterprise segment, evidenced by a greater than 50% increase in the value of deals over $1 million. Consequently, management has raised its full-year billings outlook midpoint by $100 million, with full-year revenue and billings projected to grow 12.8% and 13.9%, respectively. However, this fundamental strength is starkly contrasted by the stock's market performance and valuation. Shares have declined 19% year-to-date, substantially underperforming the security industry's 8.6% gain. Furthermore, the stock trades at a premium Price/Book ratio of 28.45X, well above the industry average of 20.4X, leading to a Zacks Value Score of D. This divergence suggests that while the company's integrated FortiOS platform provides a competitive edge, the market remains skeptical, potentially due to the high valuation or competitive threats from entrenched players like Cisco and Check Point.

Key Decisions for Investors

• Investors bullish on the secular growth of SASE and security platform consolidation could interpret the 19% year-to-date stock decline as a potential buying opportunity, given the strong underlying billings growth and upwardly revised corporate guidance.
• Caution is warranted due to the stock's significant valuation premium, with a Price/Book ratio of 28.45X, which may not be justified despite positive operational results, especially considering the stock's severe underperformance relative to its sector.
• Monitor upcoming quarters for sustained momentum in SASE and SecOps billings and large deal closures to validate that the company's growth trajectory can support its elevated valuation against intense competition from rivals like Cisco and Check Point.